Biography
Fenglin Liu is a DPhil/PhD student at the University of Oxford, where he is supervised by Professor David Clifton. He is a Clarendon Scholar at Oxford and a member of Magdalen College.
He was a finalist in the STEM for Britain 2024 scientific poster competition at the UK Houses of Parliament. He received the William James Award in 2024, which is awarded annually to one distinguished PhD student in the field of Biomedical Engineering across the UK and abroad.
His work “DrugGPT – Large Language Models for Drug Analysis” was featured in a report by the prestigious British newspaper The Guardian. His RiskAgent system was spotlighted by Oxford University as groundbreaking work in recognition of Rare Disease Day 2025.
His multimodal AI system for discharge won the Best Poster Award at the Multimodal AI Workshop 2023 held by the Alan Turing Institute. He has published papers at premier journals and conferences and served on many review committees for top-tier venues. Several of his publications have been designated as Highly Cited Papers by Google Scholar.
He has served as an area chair for ACL, AAAI, and IJCAI. He was awarded as the Distinguished Reviewer of ACL, CVPR, and IJCAI.
Research Interests
Fenglin’s research interests include Large Language Models, Machine Learning, and their applications to healthcare. Fenglin’s DPhil focuses on exploring the “warm start” of algorithmic development using data from analogous, but different, diseases from the very large repositories of data available, such that tools can be ready to deploy within 1-2 weeks of encountering a new pandemic.
Current Projects
Natural Language Processing for the Next Pandemic.
